LINX® Reflux Management System in chronic gastroesophageal reflux: A novel effective technology for restoring the natural barrier to reflux

Therapeutic Advances in Gastroenterology

Volumn 6, Issue 4, 2013, Pages 261-268

  Bonavina, Luigi ^a   Saino, Greta ^a   Lipham, John C ^b   Demeester, Tom R ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

adenocarcinoma; Barrett s; esophagitis; fundoplication; gastroesophageal reflux disease; heartburn; lower esophageal sphincter augmentation; Nissen; proton pump inhibitors; regurgitation

Indexed keywords

PROTON PUMP INHIBITOR;

ANTI REFLUX IMPLANT; BLOATING; CHRONIC DISEASE; DYSPHAGIA; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; LOWER ESOPHAGUS SPHINCTER; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; STOMACH FUNDOPLICATION; STOMACH PRESSURE;

EID: 84878342454     PISSN: 1756283X     EISSN: 17562648     Source Type: Journal    
DOI: 10.1177/1756283X13486311     Document Type: Article

References (28)

1. Becher A. El-Serag H. (2011) Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 34: 618–627.
2. Bonavina L. (2012) Assessment of surgical innovation. Innovation in Esophageal Surgery. Berlin: Springer.
3. Bonavina L. (2013) Selected commentary to “Esophageal sphincter device for gastroesophageal reflux disease”. Eur Surg. DOI: 10.1007/s10353-013-0206-z.
4. Bonavina L. de Meester T. Fockens P. Dunn D. Saino G. Bona D. et al. (2010) Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg 252: 857–862.
5. Bonavina L. Saino G. Bona D. Lipham J. Ganz R. Dunn D. et al. (2008) Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg 12: 2133–2140.
6. Dent J. El-Serag H. Wallander M. Johansson S. (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54: 710–717.
7. Fass R. Sifrim D. (2009) Management of heartburn not responding to proton pump inhibitors. Gut 58: 295–309.
8. Finks J. Wei Y. Birkmeyer J. (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20: 1698–1701.
9. Galmiche J. Hatlebakk J. Attwood S. Ell C. Fiocca R. Eklund S. et al. (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305: 1969–1977.
10. Ganz R. Peters J. Horgan S. Bemelman W. Dunst C. Edmundowicz S. et al. (2013) Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 368: 719–727.
11. Heidelbaugh J. Kim A. Chang R. Walker P. (2012) Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol 5: 219–232.
12. Hunter J. Smith C. Branum G. Waring J. Trus T. Cornwell M. et al. (1999) Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann Surg 230: 595–604; discussion 604–606.
13. Jobe B. Wallace J. Hansen P. Swanstrom L. (1997) Evaluation of laparoscopic Toupet fundoplication as a primary repair for all patients with medically resistant gastroesophageal reflux. Surg Endosc 11: 1080–1083.
14. Katz P. Gerson L. Vela M. (2012) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108: 308–328.
15. Lipham J. de Meester T. Ganz R. Bonavina L. Saino G. Dunn D. et al. (2012) The LINX(R) reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc 26: 2944–2949.
16. Lord R. de Meester S. Peters J. Hagen J. Elyssnia D. Sheth C. et al. (2009) Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease. J Gastrointest Surg 13: 602–610.
17. Malfertheiner P. Nocon M. Vieth M. Stolte M. Jaspersen D. Koelz H. et al. (2012) Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care – the ProGERD study. Aliment Pharmacol Ther 35: 154–164.
18. McColl K. Gillen D. (2009) Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology 137: 20–22.
19. Niebisch S. Fleming F. Galey K. Wilshire C. Jones C. Litle V. et al. (2012) Perioperative risk of laparoscopic fundoplication: safer than previously reported – analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2009. J Am Coll Surg 215: 61–68.
20. Richter J. Dempsey D. (2008) Laparoscopic antireflux surgery: key to success in the community setting. Am J Gastroenterol 103: 289–291.
21. Shaheen N. Hansen R. Morgan D. Gangarosa L. Ringel Y. Thiny M. et al. (2006) The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 101: 2128–2138.
22. Thijssen A. Broeders I. de Wit G. Draaisma W. (2011) Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature. Surg Endosc 25: 3127–3134.
23. Vakil N. Shaw M. Kirby R. (2003) Clinical effectiveness of laparoscopic fundoplication in a US community. Am J Med 114: 1–5.
24. Vakil N. van Zanten S. Kahrilas P. Dent J. Jones R. (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900–1920; quiz 1943.
25. Velanovich V. (1998) Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg 2: 141–145.
26. Wileman S. McCann S. Grant A. Krukowski Z. Bruce J. (2010) Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev (3): CD003243.
27. Wilson C. (2006) Adoption of new surgical technology. BMJ 332: 112–114.
28. Zerbib F. Sifrim D. Tutuian R. Attwood S. Lundell L. (2013) Modern medical and surgical management of difficult-to-treat GORD. United Eur Gastroenterol J 1: 21–31.